Post by Victoria DiBiaso

Today is one of my most anticipated days of the year- the sharing of the 2025 Sanofi Patient Community Promise Report! Why is this so important? It is because three years ago, Sanofi made a bold commitment: to fundamentally transform how we partner with patient communities across the drug lifecycle. And we are delivering on that promise — at scale across the entire company. In 2024, Sanofi became the first pharmaceutical company to publicly report patient engagement metrics, co-created with 80+ patient and caregiver organizations worldwide. This year, we go further. 🚀 What's new in our 2025 Patient Community Promise Report:  🌍 20+ local impact stories across 11+ disease areas  💻 Fully digital, accessible experience — designed with patients, for patients  📊 15+ performance metrics across 7 core functions The results speak for themselves:  ✅ 100% of our development programs, including all clinical studies are informed by patients  ✅ 85% positive feedback on scientific dialogue with patient organizations (up from 74% in 2024)  ✅ 100% of Phase 3 indications include patient-relevant drug label strategies This is important:  Patient engagement isn't optional anymore — it's essential. It enables us to deliver faster, more relevant therapies that truly meet patient needs. In 2025, we didn't just work for patients — we worked with them, as partners on the same team. And we're not stopping here 🌍 👉  Read the 2025 Patient Community Promise Report http://spkl.io/60447D5do   #SanofiStories #PatientCentricity #PatientEngagement #PatientCommunities Kersten Sharrock, M.S. Scott Williams Amy Akers Teets Eric Racine, PharmD, MBA Catherine Coulouvrat Isabela Batsu, MD Diana Rofail, PhD, C.Psychol, MBA Sophie Van Tomme Benoit ARNOULD Heather P.